MGLL and prostate carcinoma: FASN and MAGL are reported to play a role in increasing prostate cancer metastasis through in vitro and in vivo analysis and are dependent on E-FABP because of their role as cytosolic lipid transport proteins to nuclear receptors that are important for prostate cancer metastasis, along with the increase in E-FABP levels and amino acid metabolism in the process of prostate cancer metastasis [82].